Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 23317355)

1.

Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents.

Conte Neto N, Spolidorio LC, Andrade CR, S Bastos A, Guimarães M, Marcantonio E Jr.

Int J Exp Pathol. 2013 Feb;94(1):65-73. doi: 10.1111/iep.12007.

2.

Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone.

Abtahi J, Agholme F, Sandberg O, Aspenberg P.

J Oral Pathol Med. 2012 Jul;41(6):494-9. doi: 10.1111/j.1600-0714.2011.01125.x. Epub 2012 Jan 23.

PMID:
22268631
3.

Experimental investigation of relationship between trauma and bisphosphonate-related osteonecrosis.

Agaçayak KS, Yuksel H, Atilgan S, Koparal M, Uçan MC, Ozgöz M, Yaman F, Atalay Y, Acikan I.

Niger J Clin Pract. 2014 Sep-Oct;17(5):559-64. doi: 10.4103/1119-3077.141417.

4.

Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.

Kunchur R, Need A, Hughes T, Goss A.

J Oral Maxillofac Surg. 2009 Jun;67(6):1167-73. doi: 10.1016/j.joms.2009.02.004.

PMID:
19446200
5.

Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model.

Abtahi J, Agholme F, Aspenberg P.

Int J Oral Maxillofac Surg. 2013 May;42(5):632-6. doi: 10.1016/j.ijom.2013.02.007. Epub 2013 Mar 15.

PMID:
23499148
6.

Diabetes mellitus and corticotherapy as risk factors for alendronate-related osteonecrosis of the jaws: a study in Wistar rats.

Berti-Couto SA, Vasconcelos AC, Iglesias JE, Figueiredo MA, Salum FG, Cherubini K.

Head Neck. 2014 Jan;36(1):84-93. doi: 10.1002/hed.23260. Epub 2013 May 4.

PMID:
23649954
7.

Extraction socket healing in rats treated with bisphosphonate: animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients.

Ali-Erdem M, Burak-Cankaya A, Cemil-Isler S, Demircan S, Soluk M, Kasapoglu C, Korhan-Oral C.

Med Oral Patol Oral Cir Bucal. 2011 Nov 1;16(7):e879-83.

8.

Factors predicting the prognosis of oral alendronate-related osteonecrosis of the jaws: a 4-year cohort study.

Lee JJ, Cheng SJ, Wang JJ, Chiang CP, Chang HH, Chen HM, Kok SH.

Head Neck. 2013 Dec;35(12):1787-95. doi: 10.1002/hed.23235. Epub 2013 Mar 18.

PMID:
23508560
9.

Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene.

Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, Kogan R.

J Oral Maxillofac Surg. 2009 Jan;67(1):159-61. doi: 10.1016/j.joms.2008.09.015.

PMID:
19070762
11.

A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery?

O'Connell JE, Ikeagwani O, Kearns GJ.

Ir J Med Sci. 2012 Jun;181(2):237-42. doi: 10.1007/s11845-011-0790-5. Epub 2012 Jan 6.

PMID:
22223192
12.

Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

Marx RE, Cillo JE Jr, Ulloa JJ.

J Oral Maxillofac Surg. 2007 Dec;65(12):2397-410.

PMID:
18022461
13.

Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.

Morris PG, Fazio M, Farooki A, Estilo C, Mallam D, Conlin A, Patil S, Fleisher M, Cremers S, Huryn J, Hudis CA, Fornier MN.

J Oral Maxillofac Surg. 2012 Dec;70(12):2768-75. doi: 10.1016/j.joms.2011.12.028. Epub 2012 Feb 11.

PMID:
22330331
14.

Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.

Aguirre JI, Akhter MP, Kimmel DB, Pingel JE, Williams A, Jorgensen M, Kesavalu L, Wronski TJ.

J Bone Miner Res. 2012 Oct;27(10):2130-43. doi: 10.1002/jbmr.1669.

15.

Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.

Maahs MP, Azambuja AA, Campos MM, Salum FG, Cherubini K.

Head Neck. 2011 Feb;33(2):199-207. doi: 10.1002/hed.21422.

PMID:
20848442
16.

IL-17-mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws.

Zhang Q, Atsuta I, Liu S, Chen C, Shi S, Shi S, Le AD.

Clin Cancer Res. 2013 Jun 15;19(12):3176-88. doi: 10.1158/1078-0432.CCR-13-0042. Epub 2013 Apr 24.

17.

Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws.

Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, Kogan R.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Sep;106(3):389-91. doi: 10.1016/j.tripleo.2008.01.033. Epub 2008 Jun 13.

PMID:
18554944
18.

Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.

Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N.

J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.

PMID:
20728033
19.

Development of a rat model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).

Marino KL, Zakhary I, Abdelsayed RA, Carter JA, O'Neill JC, Khashaba RM, Elsalanty M, Stevens MR, Borke JL.

J Oral Implantol. 2012 Sep;38 Spec No:511-8. doi: 10.1563/AAID-JOI-D-11-00057. Epub 2011 Sep 9.

PMID:
21905888
20.

Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate.

Bitto A, Burnett BP, Polito F, Levy RM, Marini H, Di Stefano V, Irrera N, Armbruster MA, Minutoli L, Altavilla D, Squadrito F.

Br J Pharmacol. 2009 Apr;156(8):1287-95. doi: 10.1111/j.1476-5381.2008.00100.x. Epub 2009 Mar 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk